{"id":25794,"date":"2023-05-24T10:17:52","date_gmt":"2023-05-24T14:17:52","guid":{"rendered":"https:\/\/genomequebec.com\/financed-project\/personalized-medicine-in-the-treatment-of-epilepsy\/"},"modified":"2023-05-24T10:27:23","modified_gmt":"2023-05-24T14:27:23","slug":"personalized-medicine-in-the-treatment-of-epilepsy","status":"publish","type":"financed-project","link":"https:\/\/genomequebec.com\/en\/funded-projects\/personalized-medicine-in-the-treatment-of-epilepsy\/","title":{"rendered":"Personalized medicine in the treatment of epilepsy"},"content":{"rendered":"

New diagnostic test for epilepsy gives hope to patients with drug-resistant form of the disease<\/strong><\/p>\n

Epilepsy affects approximately three percent of Canadians. Unfortunately anti-epileptic drugs are ineffective in about one-third of patients, who have a drug-resistant form of the disease. This form of epilepsy is extremely expensive to treat, with costs reaching an estimated $1.7 billion in Canada in 2012.\u00a0<\/p>\n

\u00a0<\/p>\n

The goal of this project is to develop a pharmacogenomic tool for the more accurate diagnosis of various forms of epilepsy, particularly those that are drug resistant. This decision-support tool would improve the lives of patients by giving them access to diagnostic information in a timelier manner, aiding their decision about treatment options, and helping to prevent cognitive decline in children. Introducing this tool to the Canadian health care system represents potential savings of nearly $12 million per year.<\/p>\n

\u00a0<\/p>\n

To learn more about the genetic program research on epilepsy, click here<\/a>\u00a0(in\u00a0French)<\/p>\n

Co-applicants and End-users:<\/strong><\/p>\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Guy<\/td>\nRouleau<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Stephen<\/td>\nScherer<\/td>\nUniversity of Toronto<\/td>\n<\/tr>\n
Elsa<\/td>\nRossignol<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Danielle<\/td>\nAndrade<\/td>\nUniversity of Toronto<\/td>\n<\/tr>\n
Lionel<\/td>\nCarmant<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Jean<\/td>\nLachaine<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Marie-Pierre<\/td>\nDub\u00e9<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Jong<\/td>\nRho<\/td>\nUniversity of Calgary<\/td>\n<\/tr>\n
Anne-Marie<\/td>\nLaberge<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Grant<\/td>\nMitchell<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Samuel F.<\/td>\nBerkovic<\/td>\nGenetic Commission of the International league against epilepsy<\/td>\n<\/tr>\n
Steve<\/td>\nWhite<\/td>\nNIH Anti-epilectic drug discovery platform<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"featured_media":0,"template":"","class_list":["post-25794","financed-project","type-financed-project","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/financed-project\/25794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/financed-project"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/financed-project"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=25794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}